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Abstract
ABCB6 is a member of the adenosine triphosphate (ATP)-binding cassette family of transporter proteins that is increasingly
recognized as a relevant physiological and therapeutic target. Evaluation of modulators of ABCB6 activity would pave the
way toward a more complete understanding of the significance of this transport process in tumor cell growth, proliferation
and therapy-related drug resistance. In addition, this effort would improve our understanding of the function of ABCB6 in
normal physiology with respect to heme biosynthesis, and cellular adaptation to metabolic demand and stress responses.
To search for modulators of ABCB6, we developed a novel cell-based approach that, in combination with flow cytometric
high-throughput screening (HTS), can be used to identify functional modulators of ABCB6. Accumulation of protoporphyrin,
a fluorescent molecule, in wild-type ABCB6 expressing K562 cells, forms the basis of the HTS assay. Screening the Prestwick
Chemical Library employing the HTS assay identified four compounds, benzethonium chloride, verteporfin, tomatine
hydrochloride and piperlongumine, that reduced ABCB6 mediated cellular porphyrin levels. Validation of the identified
compounds employing the hemin-agarose affinity chromatography and mitochondrial transport assays demonstrated that
three out of the four compounds were capable of inhibiting ABCB6 mediated hemin transport into isolated mitochondria.
However, only verteporfin and tomatine hydrochloride inhibited ABCB6’s ability to compete with hemin as an ABCB6
substrate. This assay is therefore sensitive, robust, and suitable for automation in a high-throughput environment as
demonstrated by our identification of selective functional modulators of ABCB6. Application of this assay to other libraries
of synthetic compounds and natural products is expected to identify novel modulators of ABCB6 activity.
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Introduction
Transporters perform essential roles in cellular metabolism and
activity. They differ in membrane topology, energy coupling
mechanisms, and most importantly in substrate specificities [1–4].
Based on their sequence similarity and structural homology,
transporters are classified into six super-families [1,3]. The ATP
binding cassette transporter superfamily is the largest, comprising
seven subfamilies designated A to G [1,4]. ABC transporters are
increasingly recognized as playing important roles in normal
biology and therapeutic responses to medications in mammalian
cells. The highly conserved ABC domains of ABC transporters
provide the nucleotide-dependent engine that drives transport
[1,2].
ABCB6 belongs to the B sub-family of ABC transporters, which
includes the well-characterized human transporter ABCB1 that
was the first ABC transporter implicated in multidrug resistance,
the intracellular peptide transporters (TAP1 and TAP2) that
function in major histocompatibility complex class I antigen
presentation and ABCB5 which is essential for melanoma
induction, as a doxorubicin efflux mediator in melanomas and
xenotransplantation proliferation models [3,5]. ABCB6 is increas-
ingly recognized as a relevant physiologic and therapeutic target.
ABCB6 expression is upregulated in many tumor cell lines and in
liver tumors where it appears to promote cell survival and tumor
growth and proliferation [5–7]. ABCB6 gene is amplified in tumor
cells with acquired chemotherapeutic resistance [8–13]. ABCB6
expression is also induced under cell stress, where it promotes cell
survival [8,14–16]. Thus, ABCB6 expression could promote
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40005multiple survival strategies that are usually the hallmark of tumor
development and progression. Therefore, development of potent
and selective chemical probes that can modulate ABCB6
transporter function may have oncologic as well as pharmacologic
applications. Development of such modulators would also improve
our understanding of ABCB6 substrate specificity and ABCB6
transporter function with regards to heme biosynthesis, mitochon-
drial function, and cellular adaptation to metabolic demand and
stress.
In this report, we describe the development, optimization, and
validation of a novel robust high-throughput fluorescence based
flow cytometry assay designed to interrogate modulators of
ABCB6 activity. We have previously demonstrated that ABCB6
regulates the synthesis and accumulation of the fluorescent
compound protoporphyrin (PPIX) [14,17]. Increased ABCB6
expression in cells selected for over-expression of wild-type ABCB6
results in increased cell-associated PPIX fluorescence intensity
while having no effect on the fluorescence properties of the
molecule [14,17]. This has formed the basis of a flow cytometry
assay to develop modulators of ABCB6 activity. Using this assay,
we have identified and characterized modulators of ABCB6
activity from the Prestwick Chemical Library (PCL). The
identified chemotypes may represent leads for the development
of novel chemical probes for ABCB6.
Materials and Methods
Cells Lines and Culture Conditions
Human Erythroleukemia (K562) cells were obtained from
American Type Culture Collection (ATCC, Manassas, VA). K562
cells were engineered to constitutively express either the wild-type
ABCB6 or the mutant ABCB6 (under the control of a CMV
promoter) as described [14,17]. These cells exhibit stable
expression of ABCB6 for 60 passages (Fig. S1). Cells were cultured
as previously described [14] using modified eagle’s medium
(CellGro, VA) supplemented with 10% fetal bovine serum
(Hyclone, Logan UT) and 100 units/mL penicillin/streptomycin.
Chemicals
The Prestwick Chemical Library (http://www.prestwickchemical.fr/)
contains 1120 small molecules, 90% marketed drugs and 10%
bioactive alkaloids or related substances with a high degree of drug-
likeliness. The active compounds were selected for chemical and
pharmacological diversity and their potential for clinical trial drug
repurposing since their bioavailability and safety is well document-
ed.ThePCL2000Hwasdesignedtoreducetheriskof‘‘lowquality’’
hits, reduce the cost of the initial screening, and accelerate lead
discovery. The 1120 molecule collection of the library supersedes a
previous 880 small molecule collection. Tomatine, benzethonium
chloride (BEC), verteporfin, piperlongumine, and succinylacetone
were subsequently purchased from Sigma Chemical Co (St. Louis
Mo).
HTS Flow Cytometry and Data Analysis
The HyperCytH flow cytometry platform [18] interfaces a flow
cytometer and an autosampler that sequentially aspirates particle
suspensions from individual wells or a microtiter assay plate.
Between wells, the pump draws a bubble of air into the sample line
generating a tandem series of bubble-separated samples for
delivery to the flow cytometer. Sample and bubble volumes are
determined by the time the autosampler probe is in a well or above
a well taking in air. Accurate measurements have been demon-
strated in endpoint assays over a range of fluorescence intensities
using input cell concentrations of 1–20 million/mL and source
well volumes of 5–100 mL. Immediately after data acquisition by
the flow cytometer, specialized software (IDLeQuery) was used to
analyze the data file. A flow chart describing the general scheme of
the HTS assay is presented in Fig. S2.
General Assay and HTS Conditions
A1 0mL volume of ABCB6 overexpressing or empty vector
K562 cells, at a density of 4–5610
7 cells were transferred to 384-
well microplates containing 10 mL volume of the test compounds
in DMSO and 10% serum PBS. Test compounds were diluted in
5% serum-PBS-DMSO to obtain a final concentration of
6.67 mM. DMSO concentration was maintained at 1%, which is
well tolerated by the cells and the assay conditions (Fig. S9).
Microplates were incubated overnight at 37uC. HyperCytH
sampling consisted of 1–2 mL taken from a 20 mL well volume
at room temperature. Data analysis was performed with Hyper-
View software program to automatically detect the time-resolved
data clusters (wells) and determine the mean channel fluorescence
(MCF) by FL2 (PE) [19–21]. Acquired data were automatically
exported to Microsoft excel for calculating the assay quality
control Z’ as described [22]. The Z’ factor is a statistical parameter
utilized in high throughput screening to evaluate the ability of an
assay to identify a hit compound. Z’ signal to noise (S/N), and
signal to background (S/B) statistics were calculated using the
following equation and as described in Zhang et al 1999. Z’ =1 -
(3*STDpos + STDneg)/(ABS[AVEpos-AVneg]). In this
equation STDpos is the standard deviation of the positive controls,
STDneg is the standard deviation of the negative controls,
AVEpos is the mean of the positive controls and AVEneg is the
mean of the negative controls. The Abosrobance (ABS) represents
the absolute value of the difference between the different control
means.
Plate Configuration and Screening
384-well plates were configured with 32 control wells and 32
buffer wells. Columns 1 and 24 contained the 1% DMSO/buffer
(negative control), columns 2 and 23 with ABCB6-mutant cells in
1% DMSO/buffer. This leaves 320 wells (columns 3 - 22) to which
PCL test compounds were added. Sampling was started after
incubating the plates overnight at 37uC and 5% CO2.
Confirmatory Dose Response Assay
Test compounds (potential hit compounds) displaying activity
after the PCL screening were serially 2-fold diluted in a
concentration range from 48.8 nM to 100 mM. Assay conditions
were identical with the primary HTS assay employing ABCB6
overexpressing and vector cells. Triplicate curves were fitted by
Prism software (GraphPad Software Inc., San Diego, CA) using
nonlinear least-squares regression in a sigmoidal dose–response
model with variable slope, known as the four-parameter logistic
equation. Curve fit statistics were used to determine the half-
maximal effective concentration (EC50 in mM) and the Hill slope of
the fitted curve.
Cell Viability and Cytotoxicity
The luminescent Cell Viability Assay kit CellTiter-Glo from
Promega (Madison, WI) was used and the assay was performed
following the manufacturer’s instruction as described previously
[21]. Briefly, at the time of passage, cell suspensions (99 mL,
10,000 cells/well) were added into opaque-walled 96-well plates
(Corning, Corning, NY). After stabilization, test compounds were
added to the wells at 1 mL per well resulting in a final
concentration range from 380 nM to 100 mM. Vehicle control
HTS Assay for Functional Modulators of ABCB6
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incubated (37uC and 5% CO2) for 72 hours prior to adding
CellTiter-Glo reagents and followed by a 10 min incubation at
room temperature in the dark. Luminescence intensity (LI) was
recorded using a Wallac 1420 plate reader (PerkinElmer, Norwalk,
CT). The percentage of normalized viable cells was calculated
using the following equation: % viability =1006(LI experiment -
LI background)/(LI vehicle control - LI background).
Molecular Modeling/Docking Protein Modeling and
Docking
The sequence of the human ABCB6 transporter as extracted
from the UniProt database [23,24] (accession code: Q9NP58) was
aligned using the T-Coffee package [25] with both the Val33-
Thr626 and Leu684-Ala1271 parts of the sequence of the mouse
ABCB1a transporter retrieved from the RCSB Protein Data Bank
(PDB entry: 3G5U). The alignment was further manually refined
in order to remove the insertions and deletions in the alpha helices
(Fig. S3). The 3D model of the dimer human ABCB6 transporter
was generated using the protein structure modeling package
Modeller [26], and was prepared for docking using the standard
protocol implemented in Fred_Receptor, a wizard like graphical
utility that prepares an active site for docking with FRED
(OpenEye Scientific Software Inc. Santa Fe, NM. www.eyesopen.
com). Three dimensional (3D) conformations for the chosen
ligands (tomatine, verteporfin, benzethonium, piperlongumine,
and the endogenous substrate coproporphyrinogen III) were
generated using OMEGA (OpenEye Scientific Software Inc.
Santa Fe, NM. www.eyesopen.com) and the ligands were docked
to the protein with FRED, using the default docking parameters,
and a box big enough to include most part of the transmembrane
region. The Chemgauss3 scoring function, which uses Gaussian
smoothed potentials to measure the complementarity of ligand
poses within the active site, was used to evaluate and compare how
well the different ligands fit in the receptor binding site.
Primary Hit Validation Selectivity/specificity and
Functional Relevance
Compounds identified to be non-toxic to the primary cells were
screened for selectivity/specificity using four different assays.
1) Hemin agarose affinity chromatography. The assay
was performed as described previously [17]. Briefly, mitochondrial
lysate (20 mg) or purified ABCB6 protein (300 ng for immunoblots
and 3 mg for silver staining and coomassie staining) with a flag tag
were incubated at room temperature for 15 min in the presence of
167.5 nM hemin-agarose (Sigma, StLouis, MO). The reaction
mixture was centrifuged at 4uC. The resulting pellet was washed
thrice with 1 mL lysis buffer, resuspended in 20 mL of 2X SDS
sample-loading buffer, and then centrifuged. The supernatant
from the final spin was analyzed on a 5–20% gradient gel,
transferred to a nylon membrane, and probed with a monoclonal
antibody to the flag epitope to identify ABCB6-flag (Sigma,
StLouis, MO). A schematic representation of the hemin-agarose
affinity chromatography assay is presented in Fig. S4.
Purification of ABCB6 protein with a flag tag used in
hemin agarose affinity chromatography described
above. A detailed description of the purification protocol is
presented in a manuscript that is currently in preparation. Briefly,
HEK293 cells expressing ABCB6-flag (transduced with ABCB6-
flag lentiviral particles) were harvested and lysed in lysis buffer
(0.2%Triton X 100 in 1X PBS containing 1 mM phenylmehane-
sulfonylfluoride (PMSF), Pepstatin, Aprotinin and Leupeptin).
Following centrifugation at 1,000 rpm for 10 min at 4uC the
supernatant was incubated with 1 mL of anti-flag M2 affinity
beads (Sigma, StLouis, MO) overnight at 4uC. The antibody-
ABCB6-flag complex formed following overnight incubation was
washed twice with lysis buffer and centrifuged to remove the
supernatant. The antibody-ABCB6-flag-bead complex (pellet) was
resuspended in lysis buffer and transferred to handee spin cups
(Peirce, Rockford, IL) followed by additional washing steps using
lysis buffer and wash buffer (10 mM Tis, 0.2% Triton X-100).
ABCB6-flag protein was finally eluted from the column using
elution buffer containing Glycine and 0.2% Triton –X-100. The
eluted protein was quantified and purity analyzed by SDS-PAGE
following coomassie blue staining and silver staining.
2) Mitochondrial transport assay: Hemin
competition. The assay was performed as described previously
[17]. Briefly, mitochondrial preparations containing 20 mgo f
protein were incubated with an ATP regenerating mix along with
23 nM Fe
55-hemin in either the presence or absence of the
potential hit compound. The reaction was stopped at the indicated
time and filtered through a cellulose filter. The filter was washed
and analyzed by liquid scintillation counting. Fe
55 hemin uptake
was defined as the difference between substrate binding to
mitochondria at 4uC and after incubation at 37uC in the presence
or absence of ATP.
3) Mitochondrial transport assay: verteporfin and
tomatine uptake studies. The assay was performed as
described above with four modifications; a) to increase the power
of the assay to distinguish between ABCB6 dependent and ABCB6
independent transport we performed transport using mitochondria
isolated from cells expressing either a transport competent ABCB6
protein (ABCB6-wildtype; referred to as ABCB6) or a transport
incompetent ABCB6 protein (ABCB6-mutant; referred to as
ABCB6-MT) protein. The ABCB6-MT carries a single aminoacid
change in the walker A domain of ABCB6, which is the nucleotide
binding domain in ATP binding cassette transporters that is
essential for transport function (1, 17); b) the amount of
mitochondria used in these assays were 100 mg (mitochondrial
protein) instead of the 20 mg used in the competition studies c) in
these assays radioactive hemin was omitted and only verteporfin or
tomatine hydrochloride were used as substrates, d) following
uptake the reaction was stopped at the indicated time and instead
of filtering through a cellulose filter, the mitochondria were
pelleted at 17,0006 g for 10 min at 4uC. The pelleted
mitochondria were washed three times with transport buffer.
The final pellet was resuspended in 100 mL of acetonitrile and the
amount of verteporfin or tomatine taken up into isolated
mitochondria was analyzed using Ultra Performance Liquid
Chromatography-time-of-flight mass spectrometry (UPLC-
TOFMS) as previously described [27]. UPLC takes full advantage
of chromatographic principles to run separations using columns
packed with smaller particles for superior resolution and signal-to-
noise ratio. Increased analyte concentration and reduced chro-
matographic dispersion achieved by UPLC promote increased
electrospray ionization efficiency giving improvements in response
and in confirmation of identity. The concentration of verteporfin
and tomatine hydrochloride following uptake into mitochondria
was calculated from a standard curve generated using the
respective compounds.
4) ATPase activity assay. ATPase activity was measured as
described previously [17]. Briefly, vanadate-sensitive ATPase
activity was measured in crude mitochondrial fraction isolated
from K562-ABCB6-flag, and K562-ABCB6-Mutant-flag (K562-
MT-flag) cells by colorimetric assay as described [17]. Prepara-
tions of the isolated mitochondria containing 30 mg of protein
were incubated with the indicated concentrations of verteporfin or
tomatine hydrochloride in methanol; the reaction was started by
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activity stimulated by verteporfin and tomatine hydrochloride was
measured as nanomoles of inorganic phosphate released per
minute per milligram of protein.
Results and Discussion
Assay Development and HTS Flow Cytometry
We developed an HTS flow cytometry assay to select functional
modulators of ABCB6. The assay takes advantage of the unique
ability of ABCB6 to regulate cellular porphyrin biosynthesis [17].
Cells over expressing ABCB6 exhibit increased porphyrin
biosynthesis, which directly correlates with the level of ABCB6
expression (Fig. 1a and [17]). Furthermore, the increased cellular
porphyrin synthesis requires a functional protein, because a non-
functional transport mutant of ABCB6 is incapable of promoting
porphyrin biosynthesis [17]. Accumulation of porphyrin in cells
results in increased cell associated fluorescence intensity (Fig. 1a).
Cellular porphyrin representative of porphyrin levels was con-
firmed using succinylacetone (SA) as described [14,17]. SA is a
potent inhibitor of cellular porphyrin biosynthesis and we have
previously demonstrated that SA at a concentration of 200 mM
completely blocks cellular porphyrin biosynthesis in less than 24
hours [14,17].
Feasibility of the HTS assay to identify compounds that
functionally alter ABCB6 mediated porphyrin biosynthesis was
evaluated using the PCL 2000 library. Although the central idea
was to evaluate compounds that decreased the median channel
fluorescent (MCF) intensity by FL2 (Fig. 1b, Fig. S5a, S5b and
S5c), the assay also identified compounds that increased the MCF
intensity (Fig. S5c) suggesting that the assay is capable of
identifying both inhibitors and activators of ABCB6. The controls
were K562 cells overexpressing ABCB6 treated with DMSO alone
(negative control). Our analysis showed a tight data distribution
with Z’ factors averaging 0.61+/20.08 and a hit rate of 0.4%.
Calculations of percentage response were set to 100% at the
positive control level and 0% at the negative control level. Cutoffs
were set at three times higher than the standard deviation of mean
fluorescence values, which corresponded to a percentage response
of 58%.
To minimize false positive hits we selected only compounds that
satisfied the cutoff criteria because they concurrently decrease
fluorescence. By using the criteria used in FL2, 12 compounds
from the entire PCL set qualified as hits. However, 8 of these
compounds were flagged as potentially fluorescent as the FL2
MCF in the vector was greater than average +2X standard
deviation of DMSO control (which corresponded to the DMSO
control value measured in the ABCB6 cells). Four compounds met
the criteria (0.4% hit rate). The identified compounds were
verteporfin, benzethonium chloride, tomatine hydrochloride and
piperlongumine (Fig. 1b and Fig. S5a, S5b, S5c and S6).
Confirmatory Dose Responses
Compounds that displayed activity in the primary HTS assay
were re-tested for dose response. The four hit compounds that
decreased MCF intensity by FL2 in the primary screen were
evaluated employing ABCB6 over-expressing and vector cells to
identify compounds decreasing MCF by FL2 in a dose response
manner (dose concentration ranging from 48.8 nM to 100 mM).
All the four compounds (verteporfin, benzethonium chloride,
tomatine hydrochloride and piperlongumine) showed a dose
dependent ability to reduce ABCB6 mediated PPIX accumulation
(Fig. 2). In contrast, none of the compounds had any effect on
vector cells. Verteporfin exhibited the lowest EC50, while
piperlongumine exhibited the highest. Interestingly an increase
in tomatine hydrochloride concentration more than ,1.0 mM
leads to a rapid decrease of the MCF (Fig. 2). The differences in
MFC at each dose of these compounds for three replicates were
significant (p,0.05).
To confirm the results from our primary HTS assay and to
demonstrate that the decrease in PPIX fluorescence mediated by
the identified compounds were not associated with their ability to
alter ABCB6 expression per se we measured ABCB6 expression in
ABCB6-overexpressing cells following treatment with each of the
four compounds. As shown in Figure 2c and 2d tomatine
hydrochloride and benzethonium chloride dose dependently
reduced ABCB6-mediated PPIX fluorescence without affecting
ABCB6 expression. Similar results were observed for verteporfin
(data not shown).
Benzethonium chloride is a broad range antiseptic with a
variety of antimicrobial properties [28] and a tendency to be
potentially toxic [29]. The plant steroidal alkaloid a-tomatine has
a variety of reported activities spanning from antifungal to
immune adjuvant [30–32]. Verteporfin (trade name Visudyne),
is a benzoporphyrin derivative used as a photosensitizer for
photodynamic therapy to eliminate the abnormal blood vessels in
the eye associated with conditions such as the wet form of macular
degeneration [33,34]. Piperlongumine has anti-cancer properties
and selectively targets and kills cancer cells but leaving normal cells
unharmed [35]. It is intriguing to note that the assay detected
verteporfin, which is similar in structure to carboxylated porphyrin
derivatives such as hemin and pheophorbide A, which have been
shown to be ABCB6 substrates [17].
Cytotoxicity
A follow-up cytotoxicity assay was performed employing
ABCB6 overexpressing and vector cell lines (Fig. 3). This
experiment aimed to identify in principal those compounds that
are not toxic at the concentrations exhibiting their functional
inhibitory role by decreasing the intracellular accumulation of
porphyrin mediated by ABCB6. Interestingly, the normalized
viability of vector cells was reduced more than 80% when the
concentration of tomatine and benzethonium chloride was
.390 nM. However, viability was not reduced more than 25%
even at the highest concentration (100 mM) of verteporfin and
piperlongumine. The differences in percent-normalized viability at
each dose of these compounds for three replicates were significant
(p,0.05).
In case of ABCB6 overexpressing cells, benzethonium, verte-
porfin, tomatine and piperlongumine exhibited EC50 values of 1.9,
0.17, 0.08 and 2.23 uM, respectively. It is true that both
verteporfin and tomatine are more toxic to ABCB6 cells than
the other two compounds (Fig. 3). However, the selection of a less
toxic compound in between benzethonium and piperlongumine is
also complex. The normalized viability of ABCB6 expressing cells
was not reduced significantly up to a dose of 780 nM dose of
benzethonium, which was reduced by 40% at this concentration of
piperlongumine.
Topology and Homology Modeling of ABCB6
ABC transporters have a characteristic architecture that consists
minimally of four domains: two transmembrane domains (TMDs),
and two cytoplasmic ATP Binding domains [1]. At the sequence
level, the superfamily of ABC transporters is identified by a
characteristic set of highly conserved motifs that are present in the
ABCs.
Although the detailed folds of the TMDs can vary, they all
interact with the helical domains of the ABC domain through
HTS Assay for Functional Modulators of ABCB6
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e40005Figure 1. Assay development at University of New Mexico Center for Molecular Discovery (UNMCMD). (a) Human erythroid leukemia
cells (K562) expressing ABCB6 accumulate more porphyrins compared to the vector control cells as measured by flow cytometry. (b) Flow cytometric
HTS of Prestwick Chemical Library (PCL). The figure depicts data from a representative PCL plate demonstrating decrease in FL2 fluorescence
(representing PPIX fluorescence) mediated by verteporfin. The Y-axis displays the amount of fluorescence (FL2 log channel representing PPIX
fluorescence). The X-axis displays each well. In the assays time bins were automatically drawn around the clusters by using IDLQuery software
programs, each cluster corresponds to one well. The red square represents the PPIX fluorescence in untreated ABCB6 overexpressing cells while the
white square represents the PPIX fluorescence in vector control cells. The arrow highlights the decrease in PPIX fluorescence of ABCB6 expressing
cells in the presence of verteporfin.
doi:10.1371/journal.pone.0040005.g001
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[36]. In addition to the sequence comparisons of the ABC
domains, the structures of the binding proteins also suggest that
the hydrophobic amino acid (HAA; such as Leu, Ile, Val system)
and monosaccharide (MOS; such as ribose (RBS)) branch could
exhibit a distinct TMD fold. The structures of the binding proteins
for ABC transporters vary in their topological threading between
domains [37–39] and can be classified into three distinct categories
(designated I, II and III, which confusingly overlaps with the
nomenclature used for the TMD folds).
The homology modeling and docking results show that the best
scoring poses of the docked ligands (Fig. 4a and 4b), are positioned
in the upper part of the transmembrane region, close to the
corresponding binding site of the QZ59 inhibitor in the ABCB1a
crystal structure [40]. This is the site where verapamil is known to
bind to the ABCB1 transporter [41,42]. While we do not intend to
Figure 2. Dose response analysis of active compounds identified in the primary HTS. (a) ABCB6 expressing cells showed dose dependent
decrease in median channel fluorescence (representing PPIX fluorescence) in response to benzethonium chloride, verteporfin, and to a lesser extent
piperlongumine. In contrast vector control cells did not show any change in median channel fluorescence of FL2 (representing PPIX fluorescence) in
response to treatment with any of the four compounds. (b) EC50 values for each of the compound and their corresponding hillslope values. Results
represent mean +/2 SD with n=3. (c and d) compounds identified in the primary HTS screen do not alter ABCB6 expression in the ABCB6 over-
expressing cells. (c) immunoblot analysis of ABCB6 expression in ABCB6 overexpressing cells treated with increasing concentration of benzethonium
chloride (BCL). (d) immunoblot analysis of ABCB6 expression in ABCB6-flag overexpressing cells treated with increasing concentration of tomatine
hydrochloride (THC). In these studies ABCB6 expression was measured using a monoclonal antibody against the flag-tag. Actin is used a loading
control. Figure representative of three independent experiments.
doi:10.1371/journal.pone.0040005.g002
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notice a higher overlap between the endogenous substrate,
coproporphyrinogen III, with tomatine and verteporfin, compared
to the overlap with benzethonium and piperlongumine.
Selectivity and Validation of Compounds Identified in the
Primary HTS assay – Hemin Agarose Affinity
Chromatography Using Mitochondrial Fractions
The compounds identified in the primary HTS were evaluated
for their ability to act as functional inhibitors of ABCB6 using
hemin-agarose affinity chromatography and mitochondrial trans-
port assay [17]. We have previously demonstrated that these two
assays when used in combination have the ability to identify
substrates and potential inhibitors of ABCB6 [17]. We found that
following hemin-agarose affinity chromatography, verteporfin and
tomatine hydrochloride showed a dose dependent displacement of
ABCB6 from hemin agarose [.50% displacement of ABCB6 at
5 mM (Fig. 5)]. In contrast, neither succinylacetone (Fig. 5) a
known inhibitor of porphyrin biosynthesis nor benzethonium
chloride (data not shown) one of the compounds identified in the
HTS screen were capable of displacing ABCB6 even at a
concentration of 20 mM. These results suggest that verteporfin
and tomatine hydrochloride could be potential substrates of
ABCB6 and might be capable of interacting with the same
substrate-binding site as hemin.
Selectivity and Validation of Compounds Identified in the
Primary HTS Assay – Hemin Agarose Affinity
Chromatography Using Purified Protein
To confirm hemin interaction with ABCB6 specifically and to
extend the studies described above we performed hemin-agarose
affinity chromatography using purified ABCB6 protein. The
Figure 3. Toxicity profile for ABCB6 overexpressing and vector cells treated with the four compounds identified in the primary HTS
screen. (a) Dose dependent toxicity of the four compounds in ABCB6 overexpressing and vector cells. (b) EC50 value for each of the compound and
their corresponding hill slope values. Results represent mean +/2 SD with n=3.
doi:10.1371/journal.pone.0040005.g003
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manuscript that is currently in preparation and will not be
discussed here in detail, except to show that the purified protein
(confirmed by mass spectrometry) exists as two isforms of ,
50 kDa and ,80 kDa proteins (Fig. 6a), both of which were
recognized by the flag-antibody. Because the flag-antibody is
fused to the c-terminal tail of ABCB6, it suggests that the two
isoforms have different N-terminal sequences. We found that
following hemin-agarose affinity chromatography, only the
,80 kDa isoform was detected in immunoblots (Fig. 6b, 6c
and 6d and Fig. S7 and S8), suggesting isoform specific
interaction with hemin. As with the isolated mitochondria, both
verteporfin and tomatine hydrochloride showed a dose depen-
dent displacement of purified ABCB6 from hemin-agarose,
while no such competition was seen with succinylacetone.
Taken together results presented in Fig. 6, and Fig.S7 and S8,
demonstrate for the first time that hemin directly interacts with
ABCB6. Despite these results it is still quite possible that hemin
interaction with ABCB6 might require additional proteins that
promote hemin interaction with ABCB6. However, from the
results presented here it appears that this interaction might be
transient and is potentially not required once the hemin-ABCB6
complex is formed, because no interacting proteins were seen
following hemin-agarose-ABCB6 affinity chromatography (Fig.
S7 and S8). In addition, these results suggest that verteporfin
and tomatine hydrochloride could be potential substrates of
ABCB6 and might be capable of interacting with the same
substrate-binding site as hemin.
The results from hemin-agarose affinity chromatography is
further strengthened by the modeling studies described above
which demonstrate that both tomatine and verteporfin show
higher overlap with the endogenous substrate, coproporphyrino-
gen III (Fig. 4). Further, given that verteporfin is a carboxylated
porphyrin, similar to porphyrins that have previously been
demonstrated to be transported by ABCB6, these data suggest
that verteporfin is a substrate for ABCB6 that competes for the
same site on ABCB6 as does hemin. Thus, the identification of
verteporfin in this HTS assay highlights the capability of the assay
to identify not only inhibitors of ABCB6 but also potential
substrates.
Selectivity and Validation of Compounds Identified in the
Primary HTS Assay – Mitochondrial Transport Assay and
ATPase Activity Assay
To test further the specificity of the identified compounds to
inhibit ABCB6 function we evaluated the ability of verteporfin,
tomatine hydrochloride and benzethonium chloride to inhibit
ABCB6 mediated transport of hemin into mitochondria. We have
previously demonstrated that ABCB6 is capable of transporting
radioactive labeled hemin into isolated mitochondria and that this
assay is capable of distinguishing ABCB6 substrates from non-
substrates [17]. As shown in Figure 7, hemin uptake by isolated
mitochondria was inhibited by all three compounds with
verteporfin showing the highest inhibition followed by tomatine
hydrochloride and benzethonium chloride. The fact that ben-
zethonium chloride acts as a weak inhibitor of ABCB6 mediated
Figure 4. Topology and homology model of ABCB6 dimer with the docked ligands. (a) far and (b) close view of docking poses of selected
ligands to the human ABCB6 transporter. Coproporphyrinogen III – blue; verteporfin – green; benzethonium chloride– magenta; piperlongumine -
light blue; and tomatine hydrochloride - yellow. The Gly426-Val429, and Phe545-Pro555 parts from one ABCB6 monomer were hidden in order to
better see the ligands.
doi:10.1371/journal.pone.0040005.g004
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it does not interfere with hemin binding to ABCB6 suggests that
benzethonium chloride may function as a potential inhibitor of
ABCB6 by interacting with a site that is different from that bound
by hemin. These results presented above highlight the recurring
theme in the transporter field where the transporters appear to
have multiple substrate binding sites that promote co-operativity
either in promoting or inhibiting transport of a specific substrate.
In contrast to benzethonium chloride, both tomatine hydrochlo-
ride and verteporfin were capable of inhibiting transport as well as
Figure 5. Selectivity and validation of HTS identified compounds by hemin agarose affinity chromatography. (a) verteporfin and (b)
tomatine hydrochloride potently disrupt the interaction between ABCB6 and hemin-agarose compared with (c) succinylacetone. (d, e and f) image J
analysis of ABCB6 band intensity treated with (d) verteporfin, (e) tomatine hydrochloride and (f) succinylacetone averaged over three independent
experiments. Mitochondria isolated from K562 cells expressing ABCB6-Flag or the empty vector were incubated in the presence or absence of
increasing concentration of the indicated compound and hemin-agarose and the resulting complex was immunoblotted using a monoclonal
antibody to the flag-tag. Results are representative of 3 independent experiments. ‘*’ significantly different from untreated controls. P,0.05. ‘NS’
differences are non-significant compared to untreated control.
doi:10.1371/journal.pone.0040005.g005
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could be potential substrates of ABCB6.
To confirm our assertion above and to demonstrate that
verteporfin and tomatine hydrochloride are potential substrates of
ABCB6 we performed transport assays using these compounds in
functional mitochondria isolated from cells expressing either a
transport competent ABCB6 protein (referred to as ABCB6 in the
figure legends and Fig. 8) or a transport incompetent ABCB6
protein (referred to as ABCB6-MT) as described above in methods
and [17]. As shown in Figure 8 both verteporfin (Fig. 8a) and
tomatine hydrochloride (Fig. 8b) were taken up in an ATP
dependent manner into functional mitochondria isolated from
ABCB6 expressing cells which was significantly higher than the
uptake observed using functional mitochondria isolated from
ABCB6-MT cells.
We have previously demonstrated that ABCB6 mediated
transport of substrates is an energy-dependent process, and that
ABCB6 is a mitochondrial membrane ATPase that functions as an
active drug transporter [17]. Based on these observations we
hypothesized that ABCB6 might function as an ATPase during the
transport of verteporfin and tomatine hydrochloride. To test this
hypothesis we measured the ATPase activity of ABCB6 in the
presence and absence of ATP, and the drug, using mitochondria
isolated from ABCB6 expressing or ABCB6-MT expressing cells.
As shown in Fig. 8 both verteporfin (Fig. 8c) and tomatine
hydrochloride (Fig. 8d) stimulated vanadate-sensitive mitochon-
drial ATPase activity in ABCB6 expressing cells but not in
ABCB6-MT expressing or vector control cells. Together results
presented in Figures 7 and 8 demonstrate that verteporfin and
tomatine hydrochloride could be potential substrates of ABCB6
and highlights the robustness of the HTS assay to identify not only
potential inhibitors but also potential substrates of ABCB6.
There is increasing evidence that ABCB6 localizes to multiple
cellular compartments including the plasma membrane [9].
Although the precise identity and the substrate specificity of
ABCB6 localized to the plasma membrane are not defined, there
is a potential possibility that the differentially localized ABCB6
might have overlapping substrate specificity [9]. This could lead to
a possible erroneous generalization of the identified compounds as
either inhibitors or substrates of ABCB6 based on the primary
HTS assay. Although this is a concern that has to be considered,
the secondary assays of specificity described here can eliminate
these discrepancies in most cases as these secondary assays utilize
isolated mitochondria and purified ABCB6 protein as opposed to
whole cells used in the primary HTS assay. Further, it is
interesting to note that the purified ABCB6 protein exists as two
isoforms (Fig. 6a), very similar to what has been described by
Paterson et al [9] as the mitochondrial and plasma membrane
Figure 6. SDS-PAGE analysis of purified ABCB6 and selectivity and validation of HTS identified compounds by hemin-agarose
affinity chromatography using purified ABCB6. (a) Purified ABCB6 sample was analyzed by SDS-PAGE. The figure shows coomassie brilliant
blue staining of SDS gel (lane legends are 1, protein marker; 2, purified ABCB6-flag 2 mg protein; 3, purified ABCB6-flag 5 mg protein; 4, protein
marker; and 5, bovine serum albumin control). b) verteporfin and (c) tomatine hydrochloride potently disrupt the interaction between purified ABCB6
protein and hemin-agarose compared with (d) succinylacetone. Three hundred nanograms of purified ABCB6-flag protein was incubated in the
presence or absence of increasing concentration of the indicated compound and hemin-agarose and the resulting complex was immunoblotted
using a monoclonal antibody to the flag-tag. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0040005.g006
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verteporfin (c) tomatine hydrochloride and (e) benzethonium chloride compete for the transport of
14C-labeled hemin in the presence of ATP but not
in the presence of AMP in mitochondria isolated from ABCB6-overexpressing cells. (b, d, and f) Line graph showing dose dependent competition of
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isoforms could have different substrate specificities as only the
,80 kDa form of ABCB6 appears to interact with hemin but not
the ,50 kDa form. Although it is not clear at this time which of
the two isoforms localize to the mitochondria, based on our earlier
studies where we have shown that the ,80 kDa form of ABCB6
interacts with heme and localizes to the mitochondria we
hypothesize that the ,80 kDa form of the ABCB6 isoform
localizes to the mitochondria.
As optimized, the HTS assay is amenable to high-throughput
screening applications for identification of ABCB6 modulators and
in combination with the secondary assays can identify potential
mitochondrial ABCB6 substrates and inhibitors. The assay is also
appropriate to establish the relative potencies of active com-
pounds. Potential pitfalls include possibility of false positives due to
cytotoxic compounds or pore-forming proteins, which could allow
ABCB6 function-independent leakage of PPIX, leading to a
decrease in the overall cellular PPIX levels. Finally, although the
assay is configured to only detect compounds that block ABCB6,
(b) verteporfin, (d) tomatine hydrochloride and (f) benzethonium chloride for
14C-labeled hemin in the presence of ATP. Results representative of 3
independent experiments. ‘*’ Significantly different from untreated controls. P,0.05.
doi:10.1371/journal.pone.0040005.g007
Figure 8. Verteporfin and tomatine hydrochloride are ABCB6 transport substrates. (a) verteporfin and (b) tomatine hydrochloride are
transported by transport competent ABCB6 protein (ABCB6) in the presence of ATP which is significantly higher than transport by transport
incompetent ABCB6 protein (ABCB6-MT) in the presence of ATP in mitochondria isolated from ABCB6 or ABCB6-MToverexpressing cells. Results are
representative of three independent experiments. ‘*’ significantly different from ABCB6-MT and AMP treated ABCB6 expressing mitochondria;
P,0.05. ‘**’ significantly different from ABCB6-MT and AMP treated ABCB6 expressing mitochondria; P,0.01. (c) and (d) vanadate sensitive ATPase
activity (fold change relative to basal activity) was stimulated by (c) verteporfin and (d) tomatine hydrochloride in mitochondria from cells expressing
transport competent ABCB6 protein (ABCB6) relative to mitochondria isolated from transport incompetent ABCB6 protein (ABCB6-MT). Values are
means +/2 SEM. ‘*’ significantly different from ABCB6-MT cells at each time point; P,0.05.
doi:10.1371/journal.pone.0040005.g008
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Because ABCB6 activity is dependent on ATP hydrolysis,
compounds that affect ATP synthesis and accumulation could
also appear as false positives. However, as with the differentially
localized ABCB6, these issues can be easily resolved by secondary
validation assays and specificity studies described above.
Further analysis of the compounds identified here as well as
those resulting from future screening of the small Molecular
Libraries Small Molecule Repository (MLPCN) is expected to
yield significant inhibitors and activators of ABCB6 and potential
new ABCB6 substrates. Availability of these inhibitors, activators
and substrates in multiple classes will also be useful in
understanding the biochemical, physiological, and clinical impli-
cations of ABCB6 in development, tumorigenesis and therapy
related drug resistance.
Supporting Information
Figure S1 Human erythroleukemia cells (K562) ex-
pressing ABCB6 have stable expression of ABCB6. The
data show comparable ABCB6 expression in ABCB6 overexpress-
ing cells that have undergone either 2 or 60 passages, indicating
that ABCB6 expression in overexpressing cells is stable for upto 60
passages. Porin is used as the mitochondrial loading control.
Figure representative of 3 independent experiments.
(TIF)
Figure S2 ABCB6 high-throughput screening assay flow-
chart.
(TIF)
Figure S3 The sequence of the human ABCB6 trans-
porter (UniProt accesion code: Q9NP58) aligned with
both the Val33-Thr626 and Leu684-Ala1271 parts of the
sequence of the mouse ABCB1a (PDB code: 3G5U).
(TIF)
Figure S4 Schematic representation of ABCB6 hemin-
agarose affinity chromatography.
(TIF)
Figure S5 Flow cytometric HTS of Prestwick Chemical
Library (PCL). The figure depicts data from a representative
PCL plate demonstrating decrease in FL2 fluorescence (repre-
senting PPIX fluorescence) mediated by (a) benzethonium
chloride, (b) piperlongumine, and (c) tomatine hydrochloride
(tomatine). Figure (c) also demonstrates three potential activators
of porphyrin biosynthesis (doxorubicin, ellipticine, and hesperidin).
The Y-axis displays the amount of fluorescence (FL2 log channel
representing PPIX fluorescence). The X-axis displays each well. In
the assays time bins were automatically drawn around the clusters
by using IDLQuery software programs, each cluster corresponds
to one well. The red square represents the PPIX fluorescence in
untreated ABCB6 overexpressing cells while the white square
represents the PPIX fluorescence in vector control cells. The
arrow highlights the decrease in PPIX fluorescence of ABCB6
expressing cells in the presence of potential inhibitors while the
arrowhead highlights the increase in PPIX fluorescence in the
presence of potential activators.
(TIF)
Figure S6 Chemical structures of the identified lead
compounds, benzethonium chloride (BCL), verteporfin
(VRP) tomatine hydrochloride (THC) and piperlongu-
mine (PLG).
(TIF)
Figure S7 SDS-PAGE analysis of purified ABCB6 and
selectivity and validation of HTS identified compounds
by hemin-agarose affinity chromatography using puri-
fied ABCB6. (a) Purified ABCB6 sample was analyzed by SDS-
PAAGE. The figure shows silver staining of SDS gel (lane legends
are 1, protein marker; 2, purified ABCB6-flag 3 mg protein). b)
verteporfin and (c) tomatine hydrochloride potently disrupt the
interaction between purified ABCB6 protein and hemin-agarose.
3 mg of purified ABCB6-flag protein was incubated in the presence
or absence of increasing concentration of the indicated compound
and hemin-agarose and the resulting complex was analyzed on a
SDS-PAGE gel. The figure shows coomassie staining of SDS gel.
Results representative of two independent experiments.
(TIF)
Figure S8 Selectivity and validation of HTS identified
compounds by hemin-agarose affinity chromatography
using purified ABCB6. a) verteporfin and (b) tomatine
hydrochloride potently disrupt the interaction between purified
ABCB6 protein and hemin-agarose. Three hundred nanograms of
purified ABCB6-flag protein was incubated in the presence or
absence of increasing concentration of the indicated compound
and hemin-agarose and the resulting complex was immunoblotted
using a monoclonal antibody to the flag-tag. Results show the
entire immunoblot. Results are representative of three indepen-
dent experiments.
(TIF)
Figure S9 Viability of K562 cells exposed to DMSO.
DMSO at a concentration of 1% does not affect K562 cell survival
following 24 hr exposure.
(TIF)
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